CDSCO to consider waiving off clinical trials for orphan drugs

CDSCO to consider waiving off clinical trials for orphan drugs While currently there is no definition on orphan drugs in India, medicines that are used in treatment rare diseases, with less than five lakh patients, typically fall under this category.

No comments:

Post a Comment